Noel Federman

Universidad de Buenos Aires, Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina 
histone acetilation, memory
"Noel Federman"
Mean distance: 17.88 (cluster 6)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ogando MB, Pedroncini O, Federman N, et al. (2021) Cholinergic modulation of dentate gyrus processing through dynamic reconfiguration of inhibitory circuits. Cell Reports. 36: 109572
Zalcman G, Federman N, Romano A. (2018) CaMKII Isoforms in Learning and Memory: Localization and Function. Frontiers in Molecular Neuroscience. 11: 445
Zalcman G, Federman N, Fiszbein A, et al. (2018) Sustained CaMKII Delta Gene Expression Is Specifically Required for Long-Lasting Memories in Mice. Molecular Neurobiology
Zalcman G, Corbi N, Certo MG, et al. (2016) Heterozygous Che-1 KO Mice show deficiencies in Object Recognition Memory Persistence. Neuroscience Letters
Shen J, Meyers CA, Shrestha S, et al. (2016) Sclerostin Expression in Skeletal Sarcomas. Human Pathology
Kiyuna T, Murakami T, Tome Y, et al. (2016) Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma with Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening. Journal of Cellular Biochemistry
Murakami T, Singh AS, Kiyuna T, et al. (2016) Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget
Nowicki TS, Anderson JL, Federman N. (2015) Prospective immunotherapies in childhood sarcomas: PD1/PDL1 blockade in combination with tumor vaccines. Pediatric Research
de la Fuente V, Federman N, Zalcman G, et al. (2015) NF-κB transcription factor role in consolidation and reconsolidation of persistent memories. Frontiers in Molecular Neuroscience. 8: 50
Anderson JL, Park A, Akiyama R, et al. (2015) Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas. Plos One. 10: e0133610
See more...